Drug Information Journal - March 2009 - (Page 138) 138 MEDICAL INFORMATION Cohen content and normal variability in the interpretation of information among people. Beyond this efficiency gain, it is predicted that all other steps in the information reuse cycle can be impacted by enterprise-scale implementation of this technology. Predicted efficiency gains resulting from its use will be measurable by cycle time reductions and reduced rework activities (eg, protocol amendments). Other predicted benefits, such as improved knowledge propagation and organizational memory, will not be as amenable to short-term measurements but should manifest themselves over time by improved productivity and perceptions of improved organizational effectiveness (15). 7. 8. 9. 10. Acknowledgment—Medidata Solutions Worldwide provided financial support for this manuscript. REFERENCES 1. Bell HD, Walch KA, Katz SB. “Aristotle’s pharmacy”: the medical rhetoric of a clinical protocol in the drug development process. Tech Commun Q. 2000;9(3):249–269. 2. Katz N, Lazer D. Building effective intra-organizational networks: the role of teams. John F. Kennedy School of Government Center for Public Leadership Working Paper Series 2003;1:83–107. 3. Grant RM. Toward a knowledge-based theory of the firm. Strategic Manage J. 1996;17:109–122. 4. Newell S, Huang JC, Galliers RD, Pan SL. Implementing enterprise resource planning and knowledge management systems in tandem: fostering efficiency and innovation complementarity. Inf Organ. 2003;13(1):25–52. 5. Bierly PE, Kessler EH, Christensen EW. Organizational learning, knowledge and wisdom. J Organ Change Manage. 2000;13(6):595–618. 6. Alavi M, Leidner DE. Knowledge management 1 1. 12. 1 3. 14. 15. and knowledge management systems: conceptual foundations and research issues. MIS Q. 2001; 25(1):107–1 36. Kahn MG. Computable protocol models for interactive trial design. Drug Inf J. 2002;36(3): 487–497. DeRose SJ. Structured information: navigation, access, and control. 1995. Available at http:// xml.coverpages.org/deroseStructure.html. Accessed March 6, 2008. Ontology (information science). Wikipedia. Available at: http://en.wikipedia.org/w/index .php?title=Ontology_%28information_science %29&oldid=195699845. Accessed March 6, 2008. Clinical Data Interchange Standards Consortium. Specification for the operational data model (ODM). V.1.3 December 19, 2006. Available at: http://www.cdisc.org/models/odm/v1.3/final/ ODM1-3-0-Final.htm. Accessed March 6, 2008. Souza T, Kush R, Evans JB. Global clinical data interchange standards are here! Drug Discov Today. 2007;12(3/4):174–181. US Food and Drug Administration. Study data specifications V.1.4 August 1, 2007. Available at: http://www.fda.gov/cder/regulatory/ersr/Study data.pdf. Accessed June 5, 2008. Kahn MG, Broverman CA, Wu N, Farnsworth WJ, Manlapaz-Espiritu L. A model-based method for improving protocol quality. Appl Clin Trials. 2002; 1 1(5):40–46. Zuckerman DS. Trial by design. PharmaExec.com. June 1, 2006. Available at: http://pharmexec.find pharma.com/pharmexec/article/articleDetail.jsp ?id=333303. Accessed March 7, 2008. Jennex ME, Olfman L. Organizational memory/ knowledge effects on productivity, a longitudinal study. Proceedings of the 35th Hawaii International Conference on System Sciences (HICCS ’02). 2002; (4):1029–1038. The author has disclosed that he is a consultant to and a stock shareholder in Medidata Solutions Worldwide. http://xml.coverpages.org/deroseStructure.html http://xml.coverpages.org/deroseStructure.html http://en.wikipedia.org/w/index.php?title=Ontology_28information_science%29&oldid=195699845 http://en.wikipedia.org/w/index.php?title=Ontology_28information_science%29&oldid=195699845 http://en.wikipedia.org/w/index.php?title=Ontology_28information_science%29&oldid=195699845 http://www.cdisc.org/models/odm/v1.3/final/ODM1-3-0-Final.htm http://www.cdisc.org/models/odm/v1.3/final/ODM1-3-0-Final.htm http://www.fda.gov/cder/regulatory/ersr/Studydata.pdf http://www.fda.gov/cder/regulatory/ersr/Studydata.pdf http://www.PharmaExec.com http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=333303 http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=333303 http://pharmexec.findpharma.com/pharmexec/article/articleDetail.jsp?id=333303
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.